+91 8208210706   Ozarcare0706@gmail.com

In Stock

Glenza 40 mg Cap

Glenza 40mg Capsule contains Enzalutamide as its active ingredient. It is an anti-cancer medication used in the treatment of prostate cancer β€” a condition where abnormal cells form and grow uncontrollably in the prostate gland of men.
It helps block the action of male hormones (androgens) that stimulate cancer cell growth, thereby slowing down or stopping the spread of cancer in the body.

Original price was: ₹1.50.Current price is: ₹1.00.

Category:

Description

Uses & Benefits

  • Treatment of metastatic or advanced prostate cancer.

  • Helps control tumor growth and delay disease progression.

  • Improves survival rate and quality of life in patients with prostate cancer.

  • Can be used alone or in combination with other anti-cancer therapies.


Dosage & Administration

  • The usual recommended dose is 40mg once daily, or as prescribed by your oncologist.

  • Take the capsule whole with water, preferably at the same time every day.

  • Can be taken with or without food.

  • Treatment duration depends on medical condition and response.

Precautions

  • Use only under medical supervision.

  • Inform your doctor about any history of seizures, heart problems, liver issues, or other serious conditions.

  • Regular monitoring of liver function and blood pressure is recommended.

  • Common side effects may include:

    • Fatigue or weakness

    • Hot flashes

    • Back pain

    • Headache

    • High blood pressure

Storage

  • Store below 30Β°C, in a cool, dry place away from moisture and sunlight.

  • Keep out of reach of children and pets.

  • Do not use if the capsule pack is damaged or expired.

Manufacturer’s Note

Glenza 40mg Capsule is a trusted medication for prostate cancer management. Always use this medicine under the guidance of a qualified oncologist or healthcare professional.


Reviews

There are no reviews yet.

Be the first to review “Glenza 40 mg Cap”

Your email address will not be published. Required fields are marked *